Saturday, May 31, 2025

Latest

Cresco Labs – “Sort of” Reports Q2 Earnings

Last night, Cresco Labs (CSE: CL), released their unaudited financial results for Q2/19, well sort of…. They released a news release with key select data, and didn’t post the financial statements on Sedar. A trend common with many other MSOs, where they “release” their earnings in a news release, and then post the financial statements and MD&A weeks after.

Source: Sedar

The company did not disclose a cash flow statement, or any of the critical accounting notes, and in terms of the balance sheet the multi-billion dollar corporation posted the following:

We went back through the last 3 quarters to try to give investors a look at how the company is doing through the following lines we could obtain:

 QoQ  Δ%Q2’19Q1’19Q4’18
Revenue41.96% $    29,890.00  $  21,055  $  16,957
Gross Profit19.65% $    12,745.00  $  10,652  $  24,297
Gross Margin n/a43%51%143%
Income Taxes-15197.30% $    (5,586.00) $          37  $    3,555
Net Income-48.27% $    (3,918.00) $  (7,574) $  (2,606)
EBITDA n/a $      6,415.00  $  (4,808) $      (252)
Adjusted EBITDA1667.97% $    14,462.00  $        818  $  14,559

Commentary

At this stage it is very difficult to assess how Cresco is performing for shareholders. There are many moving parts and they will continue to need more cash. The company has completed and continues to work towards various acquisitions that will make it difficult for investors to gauge how accretive each deal looks like. The bright side is that the company is generating positive EBITDA and paying more in income taxes than most cannabis companies would dream of. A sign they are selling real cannabis and are a real operating business.

Beyond that, the company still awaits pending deals in New York, Massachusetts, Michigan and Florida. These deals will certainly alter the cap table, but give Cresco a larger footprint in tremendous growth states. As of the end of last quarter, the company had $61.1M cash on the balance sheet. Given the deals Cresco has on the table, one would assume they will be raising cash to close each deal and further build out. But hey, it’s cannabis, everyone has their next raise around the corner!


Information for this briefing was found via Sedar and Cresco Labs. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Alamos Gold Q1 Earnings: The Inside Scoop

Cerrado Gold Q4 Earnings: The Turnaround is Working

B2GOLD Q1 Earnings: Revenue Up, Production & Cash Flow Decline

Recommended

Canadian Copper: The $172M Combined Strategy PEA

ESGold Begins Concentration Tests Ahead Of First Production

Related News

Cresco Labs Enters US$282.5 Million Purchase Agreement for Tryke Companies

Cresco Labs (CSE: CL) announced this morning that it has entered a purchase agreement to...

Monday, September 16, 2019, 09:08:24 AM

Cresco Labs: Consensus First Quarter 2021 Estimates

Cresco Labs (CSE: CL) announced that they will be reporting their first quarter financials before...

Tuesday, May 25, 2021, 11:51:00 AM

Cresco Labs Finally Closes Acquisition of Origin House

The acquisition of Origin House (CSE: OH) by Cresco Labs (CSE CL) has finally closed...

Wednesday, January 8, 2020, 09:53:28 AM

Cresco Labs Reports $215 Million Net Loss For 2022

Cresco Labs (CSE: CL) saw its revenues in 2022 increase 3% over the prior year....

Thursday, March 16, 2023, 09:57:10 AM

Cresco Labs President Joe Caltabiano Resigns Effective Immediately

Cresco Labs (CSE: CL) has seen one of its co-founders resign as of this morning....

Tuesday, March 3, 2020, 08:39:14 AM